Citation: Wj. Triggs et al., VALPROATE-ASSOCIATED CARNITINE DEFICIENCY AND MALIGNANT CEREBRAL EDEMA IN THE ABSENCE OF HEPATIC-FAILURE, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 353-356
Authors:
SINGH S
VERMA M
LEELAMMA CO
NAIN K
GOEL RC
GANGULY NK
SHARMA BK
Citation: S. Singh et al., RED-CELL ACETYL CHOLINESTERASE AND PLASMA CHOLINESTERASE ACTIVITY ANDGENETIC-VARIANTS OF PLASMA CHOLINESTERASE IN NORTHWEST INDIAN ADULTS, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 357-360
Authors:
BREWSTER ME
POP E
FOLTZ RL
REUSCHEL S
GRIFFITH W
AMSELEM S
BIEGON A
Citation: Me. Brewster et al., CLINICAL PHARMACOKINETICS OF ESCALATING IV DOSES OF DEXANABINOL (HU-211), A NEUROPROTECTANT AGENT, IN NORMAL VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 361-365
Authors:
TUNCOK Y
HAZAN E
OTO O
GUVEN H
CATALYUREK H
KALKAN S
Citation: Y. Tuncok et al., RELATIONSHIP BETWEEN HIGH SERUM DIGOXIN LEVELS AND TOXICITY, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 366-368
Citation: O. Eradiri et Kk. Midha, COMPARISON OF DILTIAZEM BIOAVAILABILITY FROM 3 MARKETED EXTENDED-RELEASE PRODUCTS FOR ONCE-DAILY ADMINISTRATION - IMPLICATIONS OF CHRONOPHARMACOKINETICS AND DYNAMICS, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 369-373
Citation: H. Sourgens et al., PHARMACOKINETIC PROFILE OF CEFACLOR, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 374-380
Authors:
PULJEVIC D
SMALCELJ A
DURAKOVIC Z
GOLDNER V
Citation: D. Puljevic et al., THE INFLUENCE OF ATENOLOL AND PROPAFENONE ON QT INTERVAL DISPERSION IN PATIENTS 3 MONTHS AFTER MYOCARDIAL-INFARCTION, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 381-384
Authors:
MALAGUARNERA M
DIFAZIO I
LAURINO A
FERLITO L
ROMANO M
TROVATO BA
Citation: M. Malaguarnera et al., SERUM INTERLEUKIN-6 CONCENTRATIONS IN CHRONIC HEPATITIS-C PATIENTS BEFORE AND AFTER INTERFERON-ALPHA TREATMENT, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 385-388
Authors:
MAGOMETSCHNIGG D
BRANDT D
HOFMANN R
SIHORSCH K
STOSCHITZKY K
ZANGENEH M
ZENKER G
Citation: D. Magometschnigg et al., TREATMENT OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH A COMBINATION OF VERAPAMIL AND CAPTOPRIL - A MULTICENTER STUDY, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 389-396
Authors:
REIMANN IR
MEIERHELLMANN A
REINHART K
HOFFMANN A
Citation: Ir. Reimann et al., CONSENSUS DOCUMENT - ONCE-DAILY DOSING OF AMINOGLYCOSIDES - A SUPPLEMENT TO DOSAGE AND MONITORING IN CRITICALLY ILL PATIENTS - COMMENTS, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 397-397
Authors:
SURI A
ESTES KS
GEISSLINGER G
DERENDORF H
Citation: A. Suri et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS FOR ANALGESICS, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 307-323
Authors:
MARTINS ML
PIEROSSI MA
MORAES LA
RIBEIRO W
ABBIB E
MENDES GB
POLI A
DENUCCI G
MUSCARA MN
Citation: Ml. Martins et al., COMPARATIVE BIOAVAILABILITY OF 2 ATENOLOL TABLET FORMULATIONS IN HEALTHY MALE-VOLUNTEERS AFTER A SINGLE-DOSE ADMINISTRATION, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 324-328
Citation: Nm. Rawashdeh et al., COMPARATIVE BIOAVAILABILITY OF 2 CAPSULE FORMULATIONS OF MEFENAMIC-ACID, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 329-333
Authors:
VERGIN H
MAHR G
METZ R
EICHINGER A
NITSCHE V
MARTENS H
Citation: H. Vergin et al., ANALYSIS OF METABOLITES - A NEW APPROACH TO BIOEQUIVALENCE STUDIES OFSPIRONOLACTONE FORMULATIONS, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 334-340
Citation: R. Heinig et al., PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 341-351
Citation: Ko. Haustein, STATE-OF-THE-ART - TREATMENT OF PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE(POAD) WITH DRUGS VS VASCULAR RECONSTRUCTION OR AMPUTATION, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 266-274
Authors:
BACRACHEVA N
TYUTYULKOVA N
DRENSKA A
GORANTCHEVA J
SCHINZEL S
SCHOLL T
STOINOV A
TCHAKARSKI I
TENTCHEVA J
VLAHOV V
Citation: N. Bacracheva et al., EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS OF THE METABOLITES OF METAMIZOL, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 275-281
Authors:
YARMAN S
SANDALCI O
TANAKOL R
AZIZLERLI H
OGUZ H
ALAGOL F
Citation: S. Yarman et al., PROPHYLTHIOURACIL-INDUCED CUTANEOUS VASCULITIS, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 282-286
Authors:
BRYNNE N
STAHL MMS
HALLEN B
EDLUND PO
PALMER L
HOGLUND P
GABRIELSSON J
Citation: N. Brynne et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TOLTERODINE IN MAN - A NEW DRUG FOR THE TREATMENT OF URINARY-BLADDER OVERACTIVITY, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 287-295
Citation: Kh. Friese et al., THE HOMEOPATHIC TREATMENT OF OTITIS-MEDIA IN CHILDREN - COMPARISONS WITH CONVENTIONAL THERAPY, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 296-301
Citation: D. Loew, IS THE BIOPHARMACEUTICAL QUALITY OF EXTRACTS ADEQUATE FOR CLINICAL-PHARMACOLOGY, International journal of clinical pharmacology and therapeutics, 35(7), 1997, pp. 302-306
Citation: N. Anaizi, ONCE-DAILY DOSING OF AMINOGLYCOSIDES - A CONSENSUS DOCUMENT, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 223-226
Citation: T. Hakamaki et A. Lehtonen, METABOLIC EFFECTS OF SPIRAPRIL AND ATENOLOL - RESULTS FROM A RANDOMIZED, LONG-TERM STUDY, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 227-230
Authors:
MIDDEKE M
RICHTER WO
SCHWANDT P
HOLZGREVE H
Citation: M. Middeke et al., THE EFFECTS OF ANTIHYPERTENSIVE COMBINATION THERAPY ON LIPID AND GLUCOSE-METABOLISM - HYDROCHLOROTHIAZIDE PLUS SOTALOL VS HYDROCHLOROTHIAZIDE PLUS CAPTOPRIL, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 231-234